Carbon 60 and Autoimmunity: What the Research Actually Shows
Research Review · Cell and Animal Studies
Carbon 60 and Autoimmunity: What the Research Actually Shows
Search Carbon 60 and autoimmunity and you get two kinds of answers. Most supplement pages say nothing at all, because the word makes lawyers nervous. The rest overreach badly. The actual published research sits between those two, and it is more specific, and more interesting, than either version.
Here is what has been tested, what it showed, what it failed to show, and what is honestly still unknown.
The immune system does not need boosting here
Almost all immune marketing sells strength. Stronger defenses, higher counts, more activity. Autoimmune research runs in the opposite direction. The problem is not a weak response. It is a response that will not switch off. Immune cells stay activated, keep releasing mediators, and keep recruiting reinforcements into tissue that was never a threat in the first place.
So the useful question about any compound is not whether it raises immune activity. It is whether it changes how loudly an already activated cell signals.
Oxidative stress is a message, not just wear
Reactive oxygen species usually get described as damage. Rust. Inside an immune cell they are also messengers, and the cell makes them deliberately.
When a mast cell binds IgE, or a macrophage encounters TNF alpha, part of what happens next is a controlled burst of reactive oxygen species. That burst helps carry the signal forward through proteins like Syk, and helps switch on NF kappa B, the transcription factor that turns on inflammatory genes. Lower the burst and you turn down the volume of the message without killing the cell.
That single mechanism is what every study below is circling.
What the studies actually tested
Study 01 · Human cells and mice
Human mast cells and basophils
Ryan JJ, Bateman HR, Stover A, et al. The Journal of Immunology, 2007.
Researchers treated human mast cells and human blood basophils with fullerenes, then triggered them through the IgE receptor. Mediator release dropped significantly. The mechanism traced back to two things: blocked phosphorylation of Syk, and reduced reactive oxygen species after allergen exposure. In mice, treatment prevented the histamine release and the body temperature drop that mark anaphylaxis.
The cells were not destroyed. Their response was quieter. The authors closed the paper by naming inflammatory arthritis and multiple sclerosis as areas the finding might apply to, which is why this paper keeps getting cited in immune contexts rather than allergy ones.
Study 02 · Rats, joint injection
Arthritis in rats, and three separate cell types
Yudoh K, Karasawa R, Masuko K, Kato T. International Journal of Nanomedicine, 2009.
Water soluble C60 was injected directly into the joints of rats with adjuvant induced arthritis, twenty microliters once a week for eight weeks. Treated joints showed less synovitis and less bone resorption and destruction than untreated controls, which kept progressing.
The cell work behind it is the stronger half. C60 suppressed TNF alpha driven production of inflammatory cytokines in three different populations pulled from arthritic joints: synovial fibroblasts, infiltrating lymphocytes, and macrophages. Three cell types, one shared mechanism, which is what you would expect if the target really is the oxidative signaling step and not something specific to one lineage.
Injected into the joint, not swallowed.
Study 03 · Mice, nervous system model
The nervous system model
Basso AS, et al. The Journal of Clinical Investigation, 2008.
This one used chronic progressive experimental autoimmune encephalomyelitis in NOD mice, the standard laboratory model for progressive multiple sclerosis. The compound was ABS 75, a water soluble fullerene with an NMDA receptor blocker attached to it.
Axonal loss and demyelination were strikingly reduced. Nitrotyrosine staining, a direct fingerprint of oxidative protein damage, was intense in untreated spinal cords and virtually absent in treated ones. CD11b immune cell numbers in the spinal cord dropped sharply.
ABS 75 is a built molecule carrying a second active piece, so the fullerene does not get sole credit. What it does establish is that a fullerene core can carry a payload into the central nervous system and cut oxidative damage there.
Study 04 · Mice, two models, split result
Two arthritis models, two different answers
Dellinger A, et al. PLOS ONE, 2015.
This is the most useful study in the pile, and partly because half of it did not work.
The team tested fullerene derivatives against two separate mouse models of inflammatory arthritis. In the K/BxN serum transfer model, the compounds strikingly inhibited disease, with lower serum TNF alpha and reduced inflammation and cartilage and bone erosion on histology. In collagen induced arthritis, the same compounds produced no significant improvement.
Same molecules. Same researchers. Different model, different result. They also ran the experiment in mast cell deficient mice and still saw an effect, which told them the target reaches past mast cells into other cell populations. The mechanism they landed on involved mitochondrial membrane potential and NF kappa B suppression.
Anyone quoting the win without the miss is quoting half a paper.
Take the negative results seriously
The Dellinger null result is not the only one. The widely repeated rodent lifespan finding for C60 in oil failed to reproduce in a later mouse study, which also reported light dependent toxicity in the preparation it tested. View study
That study looked at lifespan, not immune signaling, so it does not overturn anything above. It does establish the shape of this field. Results are real, and they are also inconsistent across preparations, routes, and models.
A page that only shows you the wins is not showing you the research.
What is genuinely missing
- No human trials. There is not a single published human clinical trial of C60 in any autoimmune condition. Not one. Everything above is cell culture and animal work.
- Most studies used derivatives. ABS 75, the C70 compounds, water soluble modifications. These are engineered molecules, not the plain carbon cage.
- Most studies used injection. Into the joint, into the bloodstream. Oral intake is a different question and it has not been answered for these endpoints.
- Animal doses do not convert. Anyone handing you a human dose derived from a rat joint injection is guessing and calling it math.
So what can honestly be said
Carbon 60 is a well characterized antioxidant. That is the claim the chemistry supports and it is the claim we make. Greska's Carbon 60 supports your body's normal defenses against free radicals. It is not a treatment for any autoimmune condition, and nothing on this page should be read as saying it is.
What the research above earns is a narrower and more interesting statement. Oxidative signaling is one of the levers that keeps inflammatory activation running, fullerenes act on that lever in laboratory and animal work, and that is a mechanism worth following as the science develops. It is not a finished story. We would rather tell you that than dress it up.
If you are managing an autoimmune condition, talk to your doctor before adding anything, including this. Compounds that touch immune signaling and drugs that modulate immune function belong in the same conversation, with the person who knows your chart.
Greska's Carbon 60
Carbon 60 with no solvents, no additives, and no fillers. Third party tested. Made in Colorado.
Questions about which product fits you? Call us at 720 600 6040.
Every study referenced here is linked above so you can read it yourself. Cell culture and animal model findings do not establish effects in people.
This article is for general information only and is not medical advice. Talk with your healthcare provider before starting any supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
